Health Europa partners with Empowering PAGs on COVID-19

Health Europa will serve as a media partner for the “Empowering & Mobilizing PAGs on COVID‑19” event scheduled for October 14 in Brussels, a gathering that aims to bring together leaders from civic and patient groups to discuss ongoing challenges linked to the pandemic.

Event focus and participants

The one‑day conference, organized by the Active Citizenship Network, is invitation‑only and targets heads of patient‑advocacy groups and civil‑society organisations. Independent experts are slated to share insights on prevention strategies, vaccination policies, and service‑delivery models for COVID‑19 and its long‑term sequelae. The agenda builds on work undertaken in 2023 and aligns with broader EU and national initiatives aimed at strengthening the role of community organisations in pandemic response.

Why long COVID remains a priority

Even though the acute wave of COVID‑19 has largely receded across the WHO European Region, the health‑system burden continues. Workers still report high levels of burnout, and COVID‑related illnesses add to staffing shortages. Those shortages translate into longer wait times for patients and heightened pressure on hospitals.

Post‑COVID‑19 Condition (PCC), often called long COVID, is defined by the World Health Organization as the persistence or emergence of symptoms three months after infection, lasting at least two months without an alternative explanation. More than 200 symptoms have been recorded, with fatigue, shortness of breath, and cognitive difficulties topping the list.

Estimates suggest that 10‑20 % of people infected with the virus may experience lingering effects, though the exact figure remains uncertain. This uncertainty fuels ongoing debate about preventive measures, including the impact of vaccination on mitigating long‑term outcomes, especially as new variants such as KP.3 appear.

In practice, the presence of long COVID means patients often manage fragmented care pathways. A recent WHO study of service‑delivery models in several European countries highlighted considerable variation in how health systems manage these cases, pointing to gaps that could be addressed through clearer guidelines and better coordination between primary care providers and specialist services.

For many patients, the lack of a single, streamlined route to diagnosis and treatment creates delays that worsen health outcomes. The upcoming Brussels event seeks to give group leaders the information they need to advocate for more consistent care structures, potentially easing the burden on overstretched health services.

Implications for patient groups and health policy

By empowering civic and patient organisations, the conference hopes to translate expert knowledge into actionable policy recommendations. Participants will discuss how to improve access to accurate information, sustain vaccination campaigns, and integrate long‑COVID care into existing health‑system frameworks.

From a practical standpoint, these discussions could lead to more robust support networks for individuals dealing with persistent symptoms, ensuring that they receive timely referrals and appropriate follow‑up. Strengthening such networks may also help mitigate workforce shortages by reducing the need for repeated hospital visits.

The event highlights a broader shift toward collaborative public‑health approaches, where community voices play a central role in shaping responses to evolving health threats. As the pandemic’s effects linger, the engagement of patient advocacy groups is likely to become increasingly important in influencing both national and EU‑level health strategies.

Stakeholders anticipate lasting changes.